{
  "story_id": "c76bc5357d5eed3a6afeba5ea6bdda74",
  "desk": "drm3",
  "revision": 1,
  "published_at": "2026-11-20T09:02:00.000Z",
  "content_hash": "6d120fc1e2a18be42bd461865a067682276f1bfcbb35d3ac44cb7f94ea30f436",
  "hash_basis": "sha256 over `headline\\ndek\\nprose`, plus `\\n` + the canonical citations JSON when any source is placed, plus `\\n#blog` for blogs",
  "basis": {
    "headline": "International researchers identify new hereditary aggressive prostate cancer form",
    "dek": "Scientists discovered inherited CDK12 gene mutations cause early aggressive prostate cancer.",
    "prose": "An international research team published findings in the journal Cancer Discovery identifying inherited mutations in the CDK12 gene cause aggressive early-onset prostate cancer. [^1]\n\nAnalysis of 39,184 solid tumor patients found restricting germline genetic testing to those under age 50 would miss 72% of pathogenic variant carriers. [^2][^3] Zsofia K. Stadler, MD stated the age 50 testing cutoff is arbitrary and universal cancer genetic testing is the correct next step. [^4] Prior to this study, the scientific community believed harmful CDK12 mutations only occurred spontaneously in tumour cells and were not heritable. [^5]\n\nResearchers analysed genetic data from over 4500 patients with aggressive prostate cancer for the study. [^6] Researchers stated CDK12 can be added to existing clinical genetic screening tests with relative ease. [^7]",
    "cited": "[{\"statement\":\"An international research team published findings in the journal Cancer Discovery identifying inherited mutations in the CDK12 gene cause aggressive early-onset prostate cancer.\",\"source\":\"La Tercera\",\"instrument\":\"News\",\"claim_key\":null,\"url\":\"https://www.latercera.com/tendencias/noticia/cientificos-descubren-una-nueva-forma-de-cancer-de-prostata-hereditario-esto-dice-su-investigacion/\"},{\"statement\":\"Analysis of 39,184 solid tumor patients found restricting germline genetic testing to those under age 50 would miss 72% of pathogenic variant carriers.\",\"source\":\"healio.com\",\"instrument\":\"News\",\"claim_key\":null,\"url\":\"https://www.healio.com/news/hematology-oncology/20261116/universal-genetic-testing-in-cancer-replacing-arbitrary-age-cutoffs-is-right-move\"},{\"statement\":\"16.3% of all studied cancer patients carried at least one germline pathogenic variant.\",\"source\":\"healio.com\",\"instrument\":\"News\",\"claim_key\":null,\"url\":\"https://www.healio.com/news/hematology-oncology/20261116/universal-genetic-testing-in-cancer-replacing-arbitrary-age-cutoffs-is-right-move\"},{\"statement\":\"Zsofia K. Stadler, MD stated the age 50 testing cutoff is arbitrary and universal cancer genetic testing is the correct next step.\",\"source\":\"healio.com\",\"instrument\":\"News\",\"claim_key\":null,\"url\":\"https://www.healio.com/news/hematology-oncology/20261116/universal-genetic-testing-in-cancer-replacing-arbitrary-age-cutoffs-is-right-move\"},{\"statement\":\"Prior to this study, the scientific community believed harmful CDK12 mutations only occurred spontaneously in tumour cells and were not heritable.\",\"source\":\"La Tercera\",\"instrument\":\"News\",\"claim_key\":null,\"url\":\"https://www.latercera.com/tendencias/noticia/cientificos-descubren-una-nueva-forma-de-cancer-de-prostata-hereditario-esto-dice-su-investigacion/\"},{\"statement\":\"Researchers analysed genetic data from over 4500 patients with aggressive prostate cancer for the study.\",\"source\":\"La Tercera\",\"instrument\":\"News\",\"claim_key\":null,\"url\":\"https://www.latercera.com/tendencias/noticia/cientificos-descubren-una-nueva-forma-de-cancer-de-prostata-hereditario-esto-dice-su-investigacion/\"},{\"statement\":\"Researchers stated CDK12 can be added to existing clinical genetic screening tests with relative ease.\",\"source\":\"La Tercera\",\"instrument\":\"News\",\"claim_key\":null,\"url\":\"https://www.latercera.com/tendencias/noticia/cientificos-descubren-una-nueva-forma-de-cancer-de-prostata-hereditario-esto-dice-su-investigacion/\"}]",
    "kind": "news"
  },
  "receipt_verify": "Ed25519 over the dot-joined string `slice_hash.cursor_from.cursor_to.view.view_version.row_count`; public_key and sig are base64url of the raw 32-byte key / 64-byte signature",
  "receipt": {
    "slice_hash": "96d1baec7373edf96a0f3d4401518796cfa2102e178ea2b3b3fd6a1c50f18276",
    "cursor_from": "ingest:raw_newsroomfloor.stories:96d1baec7373edf9",
    "cursor_to": "ingest:raw_newsroomfloor.stories:96d1baec7373edf9",
    "view": "ingest:raw_newsroomfloor.stories",
    "view_version": "1",
    "row_count": 1,
    "hash_basis": "sha256 over the JSON array of {insertId, json} rows as received (normalized wire shape), computed before the BigQuery forward",
    "credits": 0.01,
    "price_per_100_rows_written": 1,
    "sig": "h_FV9EkZjnukSpPYsp38abEmLDiBcVEFYTv1DaDc-YiBIGQg3tI9ezRnZld9JjAaTvHU2QjaeLXfcixW-BpuCw",
    "public_key": "bMUigy8O0jOnBxQ4Sc-5lwhIZ8LQVAhxMbR7qESVuUE",
    "signer_path": "lakehouse/data-extract/v1",
    "alg": "Ed25519",
    "signed": true
  },
  "receipt_note": "the ingest door's signed receipt for this revision, verbatim as the door returned it",
  "generation_chain": {
    "wire": {
      "stream": "fountain_news",
      "story_id": "88989d8f96e9b0fc62bd5827fd2340db",
      "thread_id": "9159531c9e8ffcb5a4ec45d4c0b197a3",
      "thread_label": "Cancer Discovery",
      "novelty": "UPDATE",
      "content_hash": "47361dda6fb346d27ef8e1feb5086a4ad26568874d2d70128bd99a5ae562c471",
      "compose": 3,
      "last_published_at": "2026-11-20T09:02:00.000Z",
      "read_receipt": {
        "slice_hash": "29a74b6ab9dc88cfa1b7f5a4f800a09e67e38f5994854b32c6187e625de1909a",
        "cursor_from": "eyJ0cyI6IjIwMjYtMTEtMjBUMDc6NDQ6MDAuMDAwWiIsImlkIjoiOTk2MWIzM2ZiMWNkOTU2OGU2ZWNiNWIxMjQ1Njg1OTIiLCJ2IjoiMSJ9",
        "cursor_to": "eyJ0cyI6IjIwMjYtMTEtMjBUMTE6MjA6MzMuMDAwMDAwWiIsImlkIjoiMzVlNTQ0MmQyZjUyN2VhYTZkZDEyZDcxMzI0ZjUxNjkiLCJ2IjoiMSJ9",
        "view": "v_fountain_news",
        "view_version": "1",
        "row_count": 100,
        "window_days": 3,
        "bytes_scanned": 2498337,
        "credits": 8,
        "price_per_100_rows": 8,
        "sig": "IP3yEcdVtVd-gtZ6lQPjQmKHOoSYRrRcb4jmMJREXPeQQNaBZJCIM4ijbjMORcPBB9MCJrhNRgWNwdCV0TDGBA",
        "public_key": "bMUigy8O0jOnBxQ4Sc-5lwhIZ8LQVAhxMbR7qESVuUE",
        "signer_path": "lakehouse/data-extract/v1",
        "alg": "Ed25519",
        "signed": true
      },
      "landing": "air"
    },
    "written_at": "2026-11-20T12:38:09.078Z"
  },
  "cited_facts": [
    {
      "n": 1,
      "statement": "An international research team published findings in the journal Cancer Discovery identifying inherited mutations in the CDK12 gene cause aggressive early-onset prostate cancer.",
      "source": "La Tercera",
      "instrument": "News",
      "claim_key": null,
      "url": "https://www.latercera.com/tendencias/noticia/cientificos-descubren-una-nueva-forma-de-cancer-de-prostata-hereditario-esto-dice-su-investigacion/",
      "occurred_at": null,
      "published_at": null
    },
    {
      "n": 2,
      "statement": "Analysis of 39,184 solid tumor patients found restricting germline genetic testing to those under age 50 would miss 72% of pathogenic variant carriers.",
      "source": "healio.com",
      "instrument": "News",
      "claim_key": null,
      "url": "https://www.healio.com/news/hematology-oncology/20261116/universal-genetic-testing-in-cancer-replacing-arbitrary-age-cutoffs-is-right-move",
      "occurred_at": null,
      "published_at": null
    },
    {
      "n": 3,
      "statement": "16.3% of all studied cancer patients carried at least one germline pathogenic variant.",
      "source": "healio.com",
      "instrument": "News",
      "claim_key": null,
      "url": "https://www.healio.com/news/hematology-oncology/20261116/universal-genetic-testing-in-cancer-replacing-arbitrary-age-cutoffs-is-right-move",
      "occurred_at": null,
      "published_at": null
    },
    {
      "n": 4,
      "statement": "Zsofia K. Stadler, MD stated the age 50 testing cutoff is arbitrary and universal cancer genetic testing is the correct next step.",
      "source": "healio.com",
      "instrument": "News",
      "claim_key": null,
      "url": "https://www.healio.com/news/hematology-oncology/20261116/universal-genetic-testing-in-cancer-replacing-arbitrary-age-cutoffs-is-right-move",
      "occurred_at": null,
      "published_at": null
    },
    {
      "n": 5,
      "statement": "Prior to this study, the scientific community believed harmful CDK12 mutations only occurred spontaneously in tumour cells and were not heritable.",
      "source": "La Tercera",
      "instrument": "News",
      "claim_key": null,
      "url": "https://www.latercera.com/tendencias/noticia/cientificos-descubren-una-nueva-forma-de-cancer-de-prostata-hereditario-esto-dice-su-investigacion/",
      "occurred_at": null,
      "published_at": null
    },
    {
      "n": 6,
      "statement": "Researchers analysed genetic data from over 4500 patients with aggressive prostate cancer for the study.",
      "source": "La Tercera",
      "instrument": "News",
      "claim_key": null,
      "url": "https://www.latercera.com/tendencias/noticia/cientificos-descubren-una-nueva-forma-de-cancer-de-prostata-hereditario-esto-dice-su-investigacion/",
      "occurred_at": null,
      "published_at": null
    },
    {
      "n": 7,
      "statement": "Researchers stated CDK12 can be added to existing clinical genetic screening tests with relative ease.",
      "source": "La Tercera",
      "instrument": "News",
      "claim_key": null,
      "url": "https://www.latercera.com/tendencias/noticia/cientificos-descubren-una-nueva-forma-de-cancer-de-prostata-hereditario-esto-dice-su-investigacion/",
      "occurred_at": null,
      "published_at": null
    }
  ],
  "note": "A signature proves who filed this and that it has not changed since. It never makes a claim true. The dates on cited_facts (occurred_at, published_at) are the forge's, joined at read time; they are not part of the signed basis above."
}